AMN医疗服务 2024年度报告

(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☒1934 For the fiscal year endedDecember31, 2024 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 For the transition period fromto AMN HEALTHCARE SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) 06-1500476(I.R.S. EmployerIdentification No.) Delaware (State or Other Jurisdiction ofIncorporation or Organization) Suite 500Texas 75019(Zip Code) (Address of principal executive offices) Registrant’s Telephone Number, Including Area Code:(866)871-8519____________________ Securities registered pursuant to Section12(b) of the Act:Title of Each ClassTrading SymbolName of each exchange on which registeredCommon Stock, $0.01 par valueAMNNew York Stock Exchange Securities registered pursuant to Section12(g) of the Act:None.Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes x No¨ Act.Yes¨No x Indicate by check mark whether the registrant: (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and(2)has been subject to such filing requirements for the past 90 days.YesxNo¨ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule405 of RegulationS-T during the preceding 12months (or for such shorter period that the registrant was required to submitand post such files).Yesx No¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smallerreporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of theExchange Act. (Check one): Large Accelerated Filer☒Acceleratedfiler☐Non-acceleratedfiler☐Smallerreportingcompany☐Emerging growth company☐☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered publicaccounting firm that prepared or issued its audit report.Yes☒No☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.o Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).o The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price atwhich the common equity was last sold, or the average bid and asked price of such common equity, as of June 30, 2024, was$1,934,078,967based on a closing sale price of $51.23 per share. As of February18, 2025, there were38,189,048shares of common stock, $0.01 par value, outstanding.Documents Incorporated By Reference:Portions of the registrant’s definitive proxy statement for the annual meeting of stockholdersscheduled to be held on May2, 2025 have been incorporated by reference into Part III of this Form 10-K. Auditor Name:KPMG LLPAuditor Location:San Diego, CaliforniaAuditor Firm ID:185 TABLE OF CONTENTS PART I 1.Business1A.Risk Factors1B.Unresolved Staff Comments1C.Cybersecurity2.Properties3.Legal Proceedings4.Mine Safety Disclosures PART II 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities6.[Reserved]7.Management’s Discussion and Analysis of Financial Condition and Results of Operations7A.Quantitative and Qualitative Disclosures about Market Risk8.Financial Statements and Supplementary Data9.Changes In and Disagreements With Accountants on Accounting and Financial Disclosure9A.Controls and Procedures9B.Other Information9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections PART III 10.Directors, Executive Officers and Corporate Governance11.Executive Compensation12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters13.Certain Relationships and Related Transactions, and Director Independence14.Principal Accounting Fees and Services PART IV 15.Exhibits and Financial Statement Schedules16.Form 10-K SummarySignatures Refer